These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 38301049

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Restoration of microRNA-30b expression alleviates vascular calcification through the mTOR signaling pathway and autophagy.
    Xu TH, Qiu XB, Sheng ZT, Han YR, Wang J, Tian BY, Yao L.
    J Cell Physiol; 2019 Aug; 234(8):14306-14318. PubMed ID: 30701530
    [Abstract] [Full Text] [Related]

  • 3. CKAP4 contributes to the progression of vascular calcification (VC) in chronic kidney disease (CKD) by modulating YAP phosphorylation and MMP2 expression.
    Shi Y, Jin X, Yang M, Jia J, Yao H, Yuan W, Wang K, Rong S.
    Cell Signal; 2022 May; 93():110270. PubMed ID: 35108641
    [Abstract] [Full Text] [Related]

  • 4. Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells.
    Xiao Q, Tang Y, Xia J, Luo H, Yu M, Chen S, Wang W, Pu L, Wang L, Li G, Li Y.
    Ren Fail; 2022 Dec; 44(1):752-766. PubMed ID: 35509185
    [Abstract] [Full Text] [Related]

  • 5. Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling.
    Ning FL, Tao J, Li DD, Tian LL, Wang ML, Reilly S, Liu C, Cai H, Xin H, Zhang XM.
    Acta Pharmacol Sin; 2022 Mar; 43(3):624-633. PubMed ID: 34163023
    [Abstract] [Full Text] [Related]

  • 6. Wnt1 inhibits vascular smooth muscle cell calcification by promoting ANKH expression.
    Chen B, Zhao Y, Han D, Zhao B, Mao Y, Cui ZK, Chu YC, Feng L, Yin S, Wang CY, Wang X, Xu MJ, Zhao G.
    J Mol Cell Cardiol; 2019 Oct; 135():10-21. PubMed ID: 31356809
    [Abstract] [Full Text] [Related]

  • 7. NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease.
    Jin D, Lin L, Xie Y, Jia M, Qiu H, Xun K.
    FASEB J; 2022 Jan; 36(1):e22098. PubMed ID: 34918390
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sp1 Plays an Important Role in Vascular Calcification Both In Vivo and In Vitro.
    Zhang X, Li R, Qin X, Wang L, Xiao J, Song Y, Sheng X, Guo M, Ji X.
    J Am Heart Assoc; 2018 Mar 23; 7(6):. PubMed ID: 29572322
    [Abstract] [Full Text] [Related]

  • 12. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP.
    Xu TH, Sheng Z, Li Y, Qiu X, Tian B, Yao L.
    Life Sci; 2020 Nov 15; 261():118121. PubMed ID: 32693242
    [Abstract] [Full Text] [Related]

  • 13. SET8, a novel regulator to ameliorate vascular calcification via activating PI3K/Akt mediated anti-apoptotic effects.
    Bai Y, Cheng M, Jin J, Zhang H, He L, Zhou W, Zhang S, Xu J.
    Biochem Cell Biol; 2022 Apr 15; 100(2):104-114. PubMed ID: 34846946
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of miR-29a-5p involvement in osteogenic phenotype transformation and cellular regulation of vascular smooth muscle and thus influencing calcification in VSMCs in chronic kidney disease.
    Deng H, Xu H, Luo Y.
    Cell Mol Biol (Noisy-le-grand); 2022 Jul 31; 68(7):123-128. PubMed ID: 36495508
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of vascular smooth muscle cell calcification by vasorin through interference with TGFβ1 signaling.
    Luong TTD, Estepa M, Boehme B, Pieske B, Lang F, Eckardt KU, Voelkl J, Alesutan I.
    Cell Signal; 2019 Dec 31; 64():109414. PubMed ID: 31505229
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease.
    Wang PW, Pang Q, Zhou T, Song XY, Pan YJ, Jia LP, Zhang AH.
    Atherosclerosis; 2022 Apr 31; 346():36-45. PubMed ID: 35255258
    [Abstract] [Full Text] [Related]

  • 19. HDAC1-mediated deacetylation of LSD1 regulates vascular calcification by promoting autophagy in chronic renal failure.
    Zhou J, Zhou H, Liu C, Huang L, Lu D, Gao C.
    J Cell Mol Med; 2020 Aug 31; 24(15):8636-8649. PubMed ID: 32596952
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.